Key facts
- This page summarizes Emily M. Leproust's Form 4 filing for GeneDx Holdings Corp. (WGS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 27 Jun 2024, 16:18.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
Footnote F2
The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.